Florian Perner

16PUBLICATIONS
142CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursMedical molecular engineering of nucleic acids and proteinsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 20, 2026
A novel role for transcription factor NFE2 in redox regulation and chemotherapy resistance in acute myeloid leukemia.

|Jul 08, 2026
USP22 is a novel vulnerability regulating MEIS1 protein abundance and gene transcription in KMT2Ar acute leukemia.

|Jun 29, 2026
Menin-MLL inhibitors enhance JUND activity in MLLr leukemic cells contributing to tumorigenesis and therapy resistance.

|May 08, 2026
CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trials.

|Oct 27, 2025
Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML.

Viktor Fetsch, Lennard Schwöbel, Ezgi Ozyerli-Goknar

|Aug 14, 2025
Lysine-specific demethylase 1 regulates hematopoietic stem cell expansion and myeloid cell differentiation.

Hans Felix Staehle, Christoph Koellerer, Anne Marie Staehle

Pageof 3

Frequent Collaborators

6 joint publications

Scott A Armstrong

4 joint publications

Florian H Heidel

3 joint publications

Charlie Hatton

3 joint publications

Tabea Klaus